Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cosmo Pharmaceuticals SA

+ Add to Watchlist

COPN:SW

162.10 CHF 1.90 1.16%

As of 11:43:51 ET on 03/31/2015.

Company Profile for Cosmo Pharmaceuticals SA (COPN)

Cosmo Pharmaceuticals SA develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.

Contact Information

Cosmo Pharmaceuticals SA

Via C Colombo 1
Lainate, 20020
Italy
Phone: 39-02-93337614
Fax: 39-02-93337663

Key Executives for Cosmo Pharmaceuticals SA (COPN)

Mauro Severino AjaniChairman/FounderAlessandro Della ChaChief Executive Officer
Hans Christoph TannerChief Financial OfficerMarco LecchiDeputy Chief Financial Officer
Guiseppe CiprianoChief Operating OfficerLuigi MoroChief Scientific Officer
Roberto VillaChief Manufacturing OfficerAlessandro MazzettiChief Medical Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil